ArticlePDF Available

Project YES! Youth Engaging for Success: A randomized controlled trial assessing the impact of a clinic-based peer mentoring program on viral suppression, adherence and internalized stigma among HIV-positive youth (15-24 years) in Ndola, Zambia

PLOS
PLOS One
Authors:

Abstract and Figures

Background Youth-led strategies remain untested in clinic-based programs to improve viral suppression (VS) and reduce stigma among HIV-positive adolescents and young adults (AYA) in sub-Saharan Africa. In response, Project YES! placed paid HIV-positive youth peer mentors (YPM) in four HIV clinics in Ndola, Zambia including a Children’s Hospital (pediatric setting), an adult Hospital and two primary care facilities (adult settings). Methods A randomized controlled trial was conducted from December 2017 to February 2019. Consecutively recruited 15 to 24-year-olds were randomly assigned to an intervention arm with monthly YPM one-on-one and group sessions and optional caregiver support groups, or a usual care comparison arm. Survey data and blood samples were collected at baseline and at the six-month midline. Generalized estimating equation models evaluated the effect of study arm over time on VS, antiretroviral treatment (ART) adherence gap, and internalized stigma. Results Out of 276 randomized youth, 273 were included in the analysis (Intervention n = 137, Comparison n = 136). VS significantly improved in both arms (I:63.5% to 73.0%; C:63.7% to 71.3.0%) [OR:1.49, 95% CI:1.08, 2.07]. In a stratified analysis intervention (I:37.5% to 70.5%) versus the comparison (C:60.3% to 59.4%) participants from the pediatric clinic experienced a relative increase in the odds of VS by a factor of 4.7 [interaction term OR:4.66, 95% CI:1.84, 11.78]. There was no evidence of a study arm difference in VS among AYA in adult clinics, or in ART adherence gaps across clinics. Internalized stigma significantly reduced by a factor of 0.39 [interaction term OR:0.39, 95% CI:0.21,0.73] in the intervention (50.4% to 25.4%) relative to the comparison arm (45.2% to 39.7%) Conclusions Project YES! engaged AYA, improving VS in the pediatric clinic and internalized stigma in the pediatric and adult clinics. Further research is needed to understand the intersection of VS and internalized stigma among AYA attending adult HIV clinics. Trial registration ClinicalTrials.gov NCT04115813.
This content is subject to copyright.
RESEARCH ARTICLE
Project YES! Youth Engaging for Success: A
randomized controlled trial assessing the
impact of a clinic-based peer mentoring
program on viral suppression, adherence and
internalized stigma among HIV-positive youth
(15-24 years) in Ndola, Zambia
Julie A. DenisonID
1
*, Virginia M. Burke
1
, Sam Miti
2
, Bareng A. S. Nonyane
1
,
Christiana Frimpong
2
, Katherine G. Merrill
1
, Elizabeth A. Abrams
1
, Jonathan K. Mwansa
2
1Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore,
Maryland, United States of America, 2Arthur Davison Children’s Hospital, Ndola, Zambia
*jdenison@jhu.edu
Abstract
Background
Youth-led strategies remain untested in clinic-based programs to improve viral suppression
(VS) and reduce stigma among HIV-positive adolescents and young adults (AYA) in sub-
Saharan Africa. In response, Project YES! placed paid HIV-positive youth peer mentors
(YPM) in four HIV clinics in Ndola, Zambia including a Children’s Hospital (pediatric setting),
an adult Hospital and two primary care facilities (adult settings).
Methods
A randomized controlled trial was conducted from December 2017 to February 2019. Con-
secutively recruited 15 to 24-year-olds were randomly assigned to an intervention arm with
monthly YPM one-on-one and group sessions and optional caregiver support groups, or a
usual care comparison arm. Survey data and blood samples were collected at baseline and
at the six-month midline. Generalized estimating equation models evaluated the effect of
study arm over time on VS, antiretroviral treatment (ART) adherence gap, and internalized
stigma.
Results
Out of 276 randomized youth, 273 were included in the analysis (Intervention n = 137, Com-
parison n = 136). VS significantly improved in both arms (I:63.5% to 73.0%; C:63.7% to
71.3.0%) [OR:1.49, 95% CI:1.08, 2.07]. In a stratified analysis intervention (I:37.5% to
70.5%) versus the comparison (C:60.3% to 59.4%) participants from the pediatric clinic
experienced a relative increase in the odds of VS by a factor of 4.7 [interaction term
OR:4.66, 95% CI:1.84, 11.78]. There was no evidence of a study arm difference in VS
PLOS ONE
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 1 / 19
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Denison JA, Burke VM, Miti S, Nonyane
BAS, Frimpong C, Merrill KG, et al. (2020) Project
YES! Youth Engaging for Success: A randomized
controlled trial assessing the impact of a clinic-
based peer mentoring program on viral
suppression, adherence and internalized stigma
among HIV-positive youth (15-24 years) in Ndola,
Zambia. PLoS ONE 15(4): e0230703. https://doi.
org/10.1371/journal.pone.0230703
Editor: Matt A. Price, International AIDS Vaccine
Initiative, UNITED STATES
Received: October 4, 2019
Accepted: February 21, 2020
Published: April 2, 2020
Copyright: ©2020 Denison et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Data are available
under Project SOAR’s subsection of the Harvard
Dataverse: https://dataverse.harvard.edu/
dataverse/projectsoar.
Funding: This work was supported by Project
SOAR (Cooperative agreement AID-OAA-140060),
made possible by the generous support of the
American people through the United States
among AYA in adult clinics, or in ART adherence gaps across clinics. Internalized stigma
significantly reduced by a factor of 0.39 [interaction term OR:0.39, 95% CI:0.21,0.73] in the
intervention (50.4% to 25.4%) relative to the comparison arm (45.2% to 39.7%)
Conclusions
Project YES! engaged AYA, improving VS in the pediatric clinic and internalized stigma in
the pediatric and adult clinics. Further research is needed to understand the intersection of
VS and internalized stigma among AYA attending adult HIV clinics.
Trial registration
ClinicalTrials.gov NCT04115813.
Introduction
Adolescents and young adults (AYA) living with HIV access HIV care less and have lower
rates of adherence to antiretroviral therapy (ART) and viral suppression (VS) compared to
adults [17]. While there has been a sustained international call to provide support and tools
for HIV self-management behaviors among adolescents as they transition into adulthood [5,8,
9], including adhering to ART, practicing safer-sex behaviors, and transitioning to adult care
[1014], AYA in sub-Saharan Africa (SSA) do not routinely have access to youth-specific ser-
vices or opportunities to build life skills [5]. To address the unique challenges HIV-positive
AYA face during this distinct developmental stage characterized by physical, social, emotional,
and cognitive development [15] and to maximize resilience among youth, PEPFAR/USAID
guidance on the transition of care for adolescents living with HIV [16] emphasizes several key
issues:
For some adolescents living with HIV, the transition of care process includes a physical tran-
sition from a pediatric or adolescent model of care to an adult facility;
Many adolescents living with HIV in SSA already receive care in adult HIV clinics, yet still
need support to develop the skills to self-manage their HIV; and
The process of transition of care and HIV self-management is complex and a “multifaceted,
active process” that must “attend to the medical, psychosocial, and educational or vocational
needs of adolescents” [17].
Despite our knowledge of the needs of transitioning adolescents drawn from other chronic
illnesses, as well as the impact families and peers have on AYA health [1820], there is little
published literature on interventions to support HIV-positive youth and their families in SSA
[21]. For example, a 2015 review found only 14 studies on HIV-positive adolescents transition-
ing to adult care, all of which were conducted in the US or UK and the majority of which were
qualitative studies with sample sizes of 50 participants or fewer [22]. A 2016 systematic review
examined the literature to assess the effectiveness of self-management interventions for young
people across chronic illnesses. Out of 42 randomized controlled trials included in the review,
none were conducted in SSA. The authors note that most interventions focused on the medical
aspects of self-management rather than psycho-social issues [23].
To address this gap in evidence-based interventions, this study tested a peer mentoring pro-
gram that drew upon the “Five C’s” of positive youth development: competence, confidence,
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 2 / 19
President’s Emergency Plan for AIDS Relief
(PEPFAR) and United States Agency for
International Development (USAID). The contents
of this paper are the sole responsibility of the
authors and do not necessarily reflect the views of
PEPFAR, USAID, or the United States Government.
This research has also been facilitated by the
infrastructure and resources provided by the Johns
Hopkins University Center for AIDS Research, an
NIH funded program (P30AI094189), which is
supported by the following NIH Co-Funding and
Participating Institutes and Centers: NIAID, NCI,
NICHD, NHLBI, NIDA, NIMH, NIA, FIC, NIGMS,
NIDDK, and OAR. The content is solely the
responsibility of the authors and does not
necessarily represent the official views of the NIH.
Competing interests: The authors have declared
that no competing interests exist.
connection, character and caring. Particularly salient principles are confidence, the internal
sense of overall positive self-worth, and connection, the positive bonds youth have with peers,
family, community and institutions [2426]. The study also drew upon constructs from Social
Cognitive Theory including self-efficacy to perform a behavior, agency to change one’s situa-
tion and observational learning with peer mentors acting as role models [27,28].
Peer mentors, especially those who are well trained and given paid positions, have been
effective in other settings, such as the mothers2mothers program in South Africa which places
mentor mothers in clinics to work with HIV-positive pregnant women to prevent mother-to-
child HIV transmission [29] or the Restless Development program in Zambia that placed
young adults in schools to mentor students on life skills [30]. In addition, our prior research
among 311 HIV-positive adolescents in Ndola, Zambia found that 88% of participants were
interested in having a mentor, such as a young adult living with HIV, with whom to talk [31].
That same study found that 93% of interviewed youth wanted to attend group sessions with
their HIV-positive peers. Peer group interventions have shown some promise in reducing
HIV-related stigma in SSA among HIV-positive adults [32] and supporting ART adherence
among adolescents [33,34].
Drawing on this existing evidence, Project YES! trained and hired youth peer mentors liv-
ing with HIV as paid staff and placed them in four HIV clinics. By having mentors work with
youth individually and in group sessions over time, this research embodies the approach that
healthcare transition is “a continuum and not separate, discrete moves from pediatric to ado-
lescent to adult clinic settings” [35]. We hypothesize that such youth-led strategies are needed
to effectively support AYA to successfully adhere to ART and decrease internalized stigma in
order to achieve viral suppression and the 2030 UNAIDS 95-95-95 goals [36].
Materials and methods
Study design and setting
A randomized controlled trial was conducted among AYA living with HIV attending four
HIV clinics in Ndola, Zambia–one children’s hospital, one adult hospital, and two primary
health care facilities. The two hospitals each had HIV clinics with adolescent focused days and
hours. The two primary care clinics offered HIV services on specific days only. We estimated
that with a sample size calculation of 144 per group, we had 85% power to detect a difference
of 20% (an increase from 50% to 70%) between the proportions VS in the intervention versus
the comparison arms at midline, with Type 1 error of 5% and 20% loss to follow-up.
The trial was registered retrospectively at clinicaltrials.gov (NCT04115813), once authors
became aware of this requirement for publication. The authors confirm that all ongoing and
related trials for this intervention are registered; there are no ongoing trials related to this
study.
Study participants
Study participants were drawn from a population of AYA ages 15–24 attending the four HIV
clinics described above. AYA also had the option of inviting adult caregivers to the program as
well.
Eligibility. Eligible youth were between the ages of 15 to 24 years, aware of their HIV sta-
tus, had been on ART for six or more months, spoke Bemba or English, and planned to be
available to attend study activities over the next 18 months as needed. Exclusion criteria for
youth included being too sick to participate, attending boarding school, having a sibling
already enrolled in the study (one youth per household), or having participated in a prior ado-
lescent/caregiver intervention study held at two of the study sites [31].
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 3 / 19
Sampling and recruitment. A systematic sampling approach based on clinic attendance
data from Zambia’s electronic health record system (SmartCare) was initially used by trained
study staff to recruit every other eligible youth, ages 15 to 24, in the children’s hospital and 15
to 19 in the adult clinic settings, while they attended clinic. Due to slow recruitment and the
receipt of revised, decreased SmartCare estimates, the study team amended the protocol to
recruit every eligible youth who attended the clinic as a consecutive sample and increased the
age of participation at all clinics to age 24. If determined to be eligible and interested, trained
interviewers would facilitate the informed consent process, enroll the AYA participant and col-
lect baseline data.
Randomization
After completing the baseline survey, all participants were randomized to either the interven-
tion or the comparison arms. A stratified randomly permuted block randomization (block
sizes 4 and 6) was used to generate the randomization scheme. Randomization was stratified
by sex and age within each of the four clinics for a total of 16 strata. A biostatistician unaffili-
ated with the study generated a random allocation list separately for each stratum using ‘ralloc’
command [37] in STATA statistical software [38]. Pre-labeled, opaque, sealed envelopes ran-
domly sequenced were opened by trained interviewers in the presence of the participants in
numeric order to assign treatment group in a 1:1 allocation ratio. This process resulted in 139
participants assigned to the intervention and 137 assigned to the comparison study arm for
analyses.
Laboratory testing procedures
At baseline, participants also underwent HIV-1 RNA viral load testing using the CobasAmpli-
prep/CobasTaqman 96 machine (Roche Systems, Germany). Blood samples with viral loads of
1,000 copies or more per milliliter (virologic treatment failure) were further subjected to an
HIV drug resistance test using an Applied Biosystems Genetic Analyzer model3500XL (Hita-
chi, Japan) [testing protocols available on dx.doi.org/10.17504/protocols.io.bcc7iszn]. Efforts
were made to contact and switch drugs for all participants who indicated resistance to a drug
in their current ART regimen before the start of the intervention, regardless of study arm
assignment.
Data collection procedures
Recruitment, enrollment and baseline data collection occurred from December 2017 to May
2018. Data, including ART start-date and pre-ART CD4 cell count, were also collected from
participants’ medical charts. A 6-month midline follow-up assessment consisting of a survey
and blood draw was conducted from October 2018 to February 2019. The analyses presented
in this paper are based on the 6-month midline data. After the 6-month midline the study pro-
ceeded with a cross-over design with all participants receiving a form of the intervention, the
results of which will be presented in a separate manuscript.
Project YES! intervention arm. The Project YES! intervention arm consisted of several
components. First, all participants received an orientation meeting with a health care provider
(HCP), their assigned youth peer mentor (YPM), and an adult caregiver (if invited by the
youth participant). During the orientation meeting, the HCP introduced the study participant
to their YPM, reviewed the viral load test result, and shared the Project YES! goal of supporting
the youth to maintain or achieve a suppressed viral load. In the second half of the orientation
meeting, the YPM and youth participant met separately while the HCP met with the caregiver,
if present, to discuss any questions related to Project YES! or the youth’s HIV care. Following
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 4 / 19
the orientation meeting, intervention arm participants continued to meet with their assigned
YPM for one-on-one meetings once per month over six months. Participants were also invited
to monthly youth group meetings, the first of which was required in order to encourage those
youth to try a group format. These monthly youth group meetings were facilitated by YPM,
with a HCP invited to attend when clinical or technical information was needed.
Simultaneously, adult caregivers of youth participants were offered a total of three caregiver
group meetings, held every other month. These caregiver group meetings were designed to
provide adults with enhanced knowledge and skills to support their youth living with HIV.
The project also provided Youth and Caregiver Journals that participants could use to track
adherence, engage with educational topics, and reflect on their journeys. These journals drew
upon the USAID-funded AIDSTAR Transition Toolkit and the Positive Connections Youth
Group Manual [16,39]. After the midline data collection, as described above, intervention
arm participants started a maintenance phase.
Youth intervention participants attending the children’s hospital were additionally assessed
for a physical transition to the adult hospital before the start of the intervention. This assess-
ment was based on clinical eligibility (viral load status and opportunistic infections) and psy-
cho-social factors (i.e. does not have a challenge they are facing, such as moving homes or a
recent death in the family). Participants who were eligible to be transferred were then invited
to attend a group transition meeting prior to the start of the intervention to tour the adult
clinic with their HIV-positive peers and familiarize themselves with the new clinic and
assigned YPMs. The study team also planned to have a pediatric clinic staff member attend the
first two clinical visits of the newly transitioned youths to ease the transition process. However,
this program component did not occur systematically for every transitioned youth.
Youth peer mentoring training. YPMs were HIV-positive young adults between the ages
of 21–26 years who had successfully transitioned to self-management. These peer mentors
underwent a capacity-building process. First, they participated in an intensive two-week pre-
service training lead by a Training and Capacity Building Specialist that prepared them to be
skilled, valued, and paid youth mentors and employees of the health care system. The pre-ser-
vice training also included opportunities for the YPM to reflect on their own experiences of liv-
ing with HIV and assess their own self-management and self-care practices. Second, the YPMs
had a month of practice meetings with HIV-positive youth 18 years and older prior to the start
of the intervention. Third, about midway through Project YES!, the YPM underwent an in-ser-
vice training with the same Training and Capacity Building Specialist to reinforce and expand
their skills. Fourth, the YPMs met weekly as a group to discuss challenges, approaches, and
ideas. Fifth, throughout the study, YPMs were able to rely on active supportive supervision
from study team members.
Comparison arm. Participants in the comparison arm received the standard of care for
adolescents and young adults as offered at the HIV clinics, including regular clinic visits and
the option of joining monthly youth group meetings. After the midline data collection, com-
parison arm participants started the Project YES! intervention as described above, including
transitioning eligible youth from the children’s hospital to the HIV clinic in the adult hospital.
Measures
The pre-specified outcomes included viral suppression, ART adherence and internalized stigma.
Viral suppression was defined as a viral load test result of <1,000 copies/mL versus a viral
load test result of 1,000 copies/mL.
ART adherence. An ART adherence treatment gap was assessed at the two time points
through two questions: In the past three months,did you have a day when you did not take any
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 5 / 19
ART drugs?” and What were the most days in a row that you missed swallowing your drugs in
the past three months?” [40,41]. A binary outcome was generated so that a participant was con-
sidered to not have a treatment gap if they said no to missing any full days of ART drugs in the
past three months, or if they said yes and only missed one day. Otherwise, they were consid-
ered to have an ART adherence treatment gap defined as 48 consecutive hours or more in the
past three months. If the participant was missing answers to both these questions, their ART
adherence treatment gap outcome was considered missing.
Internalized stigma. Internalized stigma was measured at both time points using three
agree/disagree questions from the Internalized AIDS Stigma Scale (IA-RSS) [42], that have
been used in a previous study among a population of HIV-positive adolescents in Ndola, Zam-
bia [41]. This measure asks participants to either “agree” or “disagree” with each of the follow-
ing three statements: (1) You feel guilty that you are HIV positive; (2) You are ashamed that you
are HIV positive; and (3) You sometimes feel worthless because you are HIV positive. From this
data, a binary outcome was generated with “1” indicating that the participant answered
“agree” to at least two of the three questions, and “0” otherwise [41]. If answers to all three
were missing, this outcome was considered missing.
Independent variables adjusted for in the analyses included sex (male vs. female), age (cate-
gorized as 15–19 versus 20–24) and enrollment site (the clinic where the AYA was recruited
and enrolled). In addition, we also assessed intervention exposure as defined by the number of
one-on-one peer mentoring sessions and the number of group sessions each youth attended,
as well as if the youth had a caregiver attend any of the Project YES! caregiver sessions. Finally
we assessed potential contamination by asking the following questions at the 6-month midline
assessment of the intervention arm participants: “Have you shared anything you learned or
talked to your YPM about with other patients at the clinic who are part of Project YES!, but
who are in the other group who will start meeting the peer mentor second”. We also asked the
comparison arm participants “has anyone from the group who has been meeting with a youth
peer mentor first shared anything they learned or talked about with a peer mentor with you?”
Participants who responded yes to these questions were then read a list of Project YES! inter-
vention topics to see if program content was discussed.
Statistical analysis
This paper presents the primary analysis comparing the intervention versus comparison arms
using baseline and 6-month midline data We summarized baseline socio-demographic and
clinical characteristics of the study sample using counts and percentages for categorical vari-
ables and means and standard deviations for continuous variables. The pre-determined out-
comes for the primary analysis comparing the interventions versus the comparison arms over
time (baseline versus midline) were VS (<1,000 copies/mL), ART adherence treatment gap,
and internalized stigma among youth participants.
Viral suppression. We fitted generalized estimating equation (GEE) models with a logit
link and an unstructured correlation structure to account for the correlation among individu-
als’ measurements. As a robustness check, we also fitted a GEE model weighted by the inverse
probability of truncation, which does not assume that the losses of participants by midline
were completely at random. The primary analysis model included study arm as the main expo-
sure of interest and adjusted for time point (midline versus baseline), time point by arm inter-
action, and the variables used for stratification in the randomization: sex, age and enrollment
site. We evaluated the potential mediation effect of the length of time between baseline and
midline measurement using a generalized structural equation model, with VLS at midline as
the outcome, adjusting for age, sex and enrollment site. A stratified analysis by pediatric versus
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 6 / 19
adult HIV treatment sites, which had been specified a priori, was also conducted using a GEE
model.
ART adherence. We generated proportions of participants with a gap at both time points
(baseline and the 6-month midline) by study arm. We then fitted a GEE model to evaluate the
effect of study arm on having an ART adherence treatment gap, adjusting for time and stratifi-
cation variables.
Internalized stigma. We calculated a Cronbach’s alpha to evaluate internal consistency
among the three internalized stigma questions. A GEE model was fitted to evaluate the effect
of the intervention on internalized stigma.
Exposure. We conducted Chi-squared tests for the null hypotheses that attending at least
five out of six group meetings or having a caregiver attend any of the meetings was associated
with VS at midline.
Ethical considerations
This study was reviewed and approved by the ERES Converge Institutional Review Board in
Zambia, the Zambia Ministry of Health through the National Health Research Authority, and
the Johns Hopkins Bloomberg School of Public Health Institutional Review Board in the
United States. Participants were reimbursed 50 Kwacha (about 5.00 USD) for their time and
travel to the clinic for study-related appointments. In addition, intervention participants were
provided snacks during monthly group meetings.
In accordance with Zambian law, participants 15 to 17 years old provided written assent
and their parent/guardian provided parental permission [43]. Trained interviewers adminis-
tered tablet-based baseline surveys using Magpi software that included questions about various
background characteristics and HIV-related health outcomes as well as experiences of violence
and suicide ideation. The interviewers referred participants who reported severe violence or
thoughts of suicide in the past week to HCPs for additional care.
Results
During recruitment, the research assistants approached 373 youth the HCPs confirmed were
aware of their HIV status, of whom 74% (n = 276) enrolled into the study (Fig 1). Out of the 97
who did not enroll, 34 were not eligible, 39 requested to join later and then were not reach-
able/never returned, 16 did not obtain parental permission, and 7 declined for various reasons
including not being interested or not having travel money.
During data cleaning it was determined that three enrolled participants had been on ART
for less than six months. These three participants were subsequently excluded from analyses
for not meeting the eligibility criteria, bringing the analysis sample to 273. At baseline, the 137
participants randomly assigned to the intervention arm and the 136 to the comparison arm
were balanced with respect to key demographic and clinical characteristics (Table 1). The aver-
age age was 19 years (range 15–24) and 162 (59.3%) were female. The majority, 240 (87.9%)
had completed at least primary school. Most (n = 198, 72.5%) self-reported having acquired
HIV perinatally. The median CD4 count prior to ART initiation was 284 (IQR 154, 453)
among the 187 participants with available pre-ART CD4 cell count data and the median num-
ber of years on ART was 7.3 (IQR 3.5, 9.9). Within each study arm, the time between baseline
and midline viral load (VL) measurements varied substantially among participants, with an
overall median of 38.3 weeks (IQR 31.0, 42.4). As part of the intervention, 23 participants with
VS and no known psycho-social issues consented and moved from the children’s hospital to
the adult hospital clinic.
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 7 / 19
At midline 92% of participants allocated to the Intervention group (n = 126) and 85% of the
Comparison group (n = 115) completed a survey and blood draw. Results from the primary
analyses on VS, ART adherence treatment gap, and internalized stigma are presented below.
No known unintended harmful effects of the intervention were found.
Viral suppression
Fig 2 shows the counts and percentages of participants with VS at baseline and midline by study
arm. At midline, 20 participants in the comparison arm and 11 in the intervention arm were lost
to follow-up (two youth from each study arm died before starting intervention activities, none of
whom were suppressed at baseline). VS was similar in both arms and increased from baseline val-
ues of 63.7% and 63.5% in the comparison and intervention arms respectively, to 71.3% and 73.0%
at midline. The results of the GEE model confirmed that the odds of VS was similar between arms
[Odds ratio (OR):1.03, 95% Confidence Interval (CI):0.68, 1.57]. The GEE model also showed a
Fig 1. Consort diagram.
https://doi.org/10.1371/journal.pone.0230703.g001
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 8 / 19
significant increase in VS between baseline and midline in both arms [OR: 1.49, 95% CI:1.08,
2.07], and no evidence of an interaction between study arm and time. As such, the final primary
model for this analysis did not include the interaction term. The inverse probability weighted esti-
mate had similar results: The odds of VS was similar between arms [OR 1.02, 95% CI: 0.66, 1.55],
and there was a significant increase in VS between baseline and midline in both arms [OR 1.52,
95% CI: 1.09, 2.10], and no evidence of an interaction between study arm and time.
The results also show that there was no evidence of a mediation effect of the length of time
between baseline and midline VL measurements [indirect effect: -.034, 95% CI: -0.12, 0.05]
and there was no significant partial effect of study arm on the time between baseline and mid-
line [partial effect: -.2,8 95% CI: -0.68, 0.11]
Table 1. Baseline socio-demographics and clinical characteristics of youth participants.
Intervention (%) Comparison (%) Total (%)
Participants 137 (50.18) 136 (49.82) 273 (100.00)
Mean age in years (range) 19.12 (15–24) 19.10 (15–24) 19.11 (15–24)
Age
15–19 years old 87 (63.50) 87 (63.97) 174 (63.74)
20–24 years old 50 (36.50) 49 (36.03) 99 (36.26)
Sex
Female 82 (59.85) 80 (58.82) 162 (59.34)
Male 55 (40.15) 56 (41.18) 111 (40.66)
Primary School
Did not complete primary school 20 (14.60) 11 (8.09) 31 (11.36)
Completed primary school 117 (85.40) 123 (90.44) 240 (87.91)
Missing - 2 (1.47) 2 (0.73)
How acquired HIV
From parents 97 (70.80) 101 (74.26) 198 (72.53)
Through sex 11 (8.03) 16 (11.76) 27 (9.89)
Another way 10 (7.30) 4 (2.94) 14 (5.13)
Don’t know 18 (13.14) 14 (10.29) 32 (11.72)
Missing 1 (0.73) 1 (0.74) 2 (0.73)
Baseline VL suppression
(<1000 copies/ml) 87 (63.50) 86 (63.24) 173 (63.37)
Missing - 1 (0.74) 1 (0.37)
Pre-ART CD4 count
median (25
th
, 75
th
) 285.5 (158–452) 280 (149–487) 284 (154–453)
0–349 61 (44.53) 57 (41.91) 118 (43.22)
350–499 12 (8.76) 14 (10.29) 26 (9.52)
500+ 21 (15.33) 22 (16.18) 43 (15.75)
Missing 43 (31.39) 43 (31.62) 86 (31.50)
Years on ART
median (25
th
, 75
th
) 7.19 (3.34–9.80) 7.45 (4.16–10.05) 7.28 (3.49–9.91)
<3 years 32 (23.36) 27 (19.85) 59 (21.61)
3–6 years 21 (15.33) 24 (17.65) 45 (16.48)
6+ years 83 (60.58) 83 (61.03) 166 (60.81)
Missing 1 (0.73) 2 (1.47) 3 (1.10)
Weeks between baseline & midline
median (25
th
, 75
th
) 37.57 (30.00–41 71) 39.00 (32.71–43.43) 38.29 (31.00–42.43)
https://doi.org/10.1371/journal.pone.0230703.t001
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 9 / 19
Viral suppression analysis stratified by treatment site type (pediatric versus
adult)
Figs 3and 4show VS at baseline and midline by study arm and by the type of site (pediatric or
adult) where the participant received the intervention. In the children’s hospital, VS at baseline
was 60.3% and 37.5% for the comparison and intervention arms respectively. The comparison
arm did not show a change by midline (59.4% suppressed) while the intervention arm
improved to 70.5%. The GEE model for the pediatric site confirmed that at baseline, the inter-
vention arm had a significantly lower level of suppression than the comparison arm [OR:0.36,
95% CI:0.17,0.79]. Among comparison arm participants, the odds of VS did not increase
at midline relative to baseline [OR:0.91, 95% CI:0.52,1.62]. There was a significant arm by
time interaction with the intervention arm participants experiencing a relative increase in the
odds of VS by a factor of 4.7 relative to comparison arm [interaction term OR:4.66, 95%
CI:1.84,11.78].
In the adult clinic settings, VS at baseline was 67.7% and 77.5% for the comparison and
intervention arms, respectively. The comparison arm improved to 86.3% suppressed by mid-
line while the intervention arm changed slightly to 74.4%. The GEE model for the adult sites
showed that among the comparison arm participants, time had a significant effect so that the
odds of VS at midline were three times higher than at baseline [OR:2.99, 95% CI:1.27,7.04].
Furthermore, among the intervention arm participants, there was a significant relative reduc-
tion in the odds of VS by midline compared to the comparison arm participants [interaction
OR:0.27, 95% CI:0.10, 0.79].
Fig 2. Viral suppression at baseline and midline by study arm.
https://doi.org/10.1371/journal.pone.0230703.g002
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 10 / 19
ART adherence
Fig 5 shows that among the comparison arm participants 44 (32.6%) at baseline, and 39
(33.9%) at midline, reported an ART adherence treatment gap of 48 consecutive hours or
more in the past three months. Among the intervention participants, 62 (45.3%) at baseline,
and 43 (34.4%), at midline reported an ART adherence treatment gap. The GEE model indi-
cates that the intervention had significantly higher odds of treatment gap than the comparison
arm at baseline [OR:1.74, 95% CI:1.06, 2.86]. Having a treatment gap did not change for the
comparison group between baseline and midline [OR:1.05, 95% CI: 0.68, 1.61], but there was a
notable relative change for the participants in the intervention arm [OR interaction term: 0.63,
95% CI: 0.35, 1.13]
Internalized stigma: Feelings of guilt, shame, worthlessness
The Cronbach’s alpha for the three items of internalized stigma was 0.74 at baseline and 0.73
at midline. Fig 6 shows that in the comparison arm, 61 (45.2%) participants at baseline and 46
(39.7%) participants at midline reported at least two of these feelings. In the intervention arm,
these feelings were prevalent among 69 (50.4%) participants at baseline which was reduced to
32 (25.4%) at midline, suggesting a potential time by arm interaction term. The GEE model
shows that there was no statistically significant difference between baseline and midline
among comparison participants [OR:0.83, 95% CI:0.54,1.29], but there was evidence of an
interaction so that for intervention arm participants, the odds of having these feelings were sig-
nificantly reduced by a factor of 0.39 relative to the reduction in the comparison arm [interac-
tion terms OR:0.39, 95% CI :0.21,0.7].
Fig 3. Viral suppression at baseline and midline: Pediatric clinic only.
https://doi.org/10.1371/journal.pone.0230703.g003
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 11 / 19
Exposure. Among the 126 intervention arm participants with a midline viral load test,
120 (95%) attended an orientation meeting, and the majority (93 [73.8%]) attended five or
six one-on-one meetings with a YPM (Table 2). Given a lack of variability in attendance and
the small numbers when stratified by VS, a further analysis to explore the potential relation-
ship between VS and Project YES! exposure to one-on-one meetings was not conducted.
Almost half (57 [45.2%]) of the participants attended five or six group meetings. There was
no significant association between attending at least five youth group meetings and VS at
midline (Chi-squared p-value = 0.66). In terms of caregiver support, 59 (47%) of youth had
at least one caregiver who attended one Project YES! session. There was no significant asso-
ciation between having a caregiver attend at least one of the meetings and VS at midline
(Chi-squared p-value = 0.14). We evaluated baseline characteristics to see if they were asso-
ciated with caregiver attendance and found that younger participants (15–19 years old)
were more likely to have a caregiver attend versus the older (20–24 years old) participants
(51.7% vs 28% p-value = 0.007). There was no evidence of an association with sex nor inter-
vention site.
We also assessed potential contamination between the two study arms. Overall, across all
the clinics, less than 5% (N = 12, 4.96%) of participants at the 6-month midline reported they
had talked with youth in the other arm about session content (5 intervention group partici-
pants and 7 comparison group participants). The topics most frequently discussed across both
study arms were “adherence or taking your ART drugs” (N = 9, 3.72%) followed by “Taking
care of your own health [self-management]” (n = 7, 2.89%) and “viral load test results and how
to suppress HIV in the blood” (n = 7, 2.89%).
Fig 4. Viral suppression at baseline and midline: Adult clinics only.
https://doi.org/10.1371/journal.pone.0230703.g004
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 12 / 19
Fig 5. ART Adherence Treatment Gap (48 hour or more in the past 3 months) at baseline and midline by study
arm.
https://doi.org/10.1371/journal.pone.0230703.g005
Fig 6. Self-Stigma at baseline and midline by study arm.
https://doi.org/10.1371/journal.pone.0230703.g006
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 13 / 19
Discussion
YPMs, when well trained and paid, are a feasible and effective way to reduce internalized
stigma and achieve VS among AYA living with HIV. Through a process of capacity building,
these young people, most of whom had never held formal employment before, were able to
gain the skills and self-confidence to share their experiences to mentor AYA and to become
valued and skilled clinic employees.
In this context, mentoring is substantially different from being a peer educator. While pro-
viding accurate information as a trustworthy peer source is a critical component of both edu-
cating and mentoring, mentoring also encompasses active role-modeling, listening, and
problem-solving based on the shared experience of living with HIV. It is this shared experience
coupled with a clear understanding of boundaries that allowed the Project YES! YPMs to serve
as empowered role models, demonstrating the behaviors of positive living and HIV self-man-
agement. Boundaries were particularly important because the YPMs were not trained to be
counselors or to attempt to resolve certain complex issues AYA may face, such as experiences
of violence and/or suicide ideation. Knowing one’s role, boundaries, and when to refer AYA
clients to clinical staff were important aspects of the YPM capacity-building process. Overall,
the YPMs took ownership of and shaped program delivery, becoming the experts. This
approach complements and builds upon existing support in Zambia for adolescent engage-
ment in HIV care as illustrated by the Ministry of Health’s Facilitator’s Guide for Adolescent
Peer Educators [44]. The Project YES! youth-driven process was also well received, as indi-
cated by the high uptake of the one-on-one meetings and represents an important approach to
addressing the needs of AYA living with HIV.
A main finding of Project YES! was the significant decrease in internalized stigma experi-
enced by intervention arm participants across all study sites. AYA are in a developmental stage
when they are “developing and consolidating their sense of self” [45], and the impact of inter-
nalized stigma among this age group is not well studied [46]. In a systematic review of stigma-
reduction interventions in low- and middle-income countries, the authors found only one
study that focused on youth [46,47]. This study used motivational interviewing to change sex-
ual risk behaviors and alcohol use among Thai youth and did not find evidence of an impact
on internalized stigma. Project YES! addresses this distinct gap in knowledge by providing crit-
ical intervention data on how to reduce internalized stigma. These results further support a
Table 2. Exposure to the Project YES! and viral load suppression at follow-up among intervention arm participants (n = 126).
VL Suppression (%) Non-VL suppression (%) Total
Orientation mtg
Yes 87 (94.6%) 33 (97.1%) 120 (95.2%)
No 5 (5.4%) 1 (2.9%) 6 (4.8%)
One-on-one YPM mtgs
0–4 25 (27.2%) 8 (23.5%) 33 (26.1%)
5–6 67 (72.8%) 26 (76.5%) 93 (73.8%)
Group YPM mtgs
0–4 54 (58.7%) 15 (44.1%) 69 (54.8%)
5–6 38 (41.3%) 19 (55.9%) 57 (45.2%)
Any caregiver engagement
Yes 42 (45.7%) 17 (50.0%) 59 (46.8%)
No 50 (54.3%) 17 (50.0%) 67 (53.2%)
11 lost to follow-up in the Intervention Arm
https://doi.org/10.1371/journal.pone.0230703.t002
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 14 / 19
growing body of literature on the relationship between internalized stigma, identity, develop-
mental stage and chronic illness outcomes among AYA [4850].
Another key finding was the relative increase of 4.7 in VS among AYA intervention versus
comparison participants in the pediatric clinic at the children’s hospital. This finding provides
important evidence on the impact YPMs have when working in collaboration with AYA cli-
ents, clinic staff and caregivers. Evidence of this effect, however, was not found in the adult set-
ting. In the adult setting, the intervention arm had significantly greater VS at baseline than the
comparison arm, possibly due in part to the fact that 23 virally suppressed participants from
the children’s hospital clinic were transitioned to the adult hospital before the start of study
activities as part of the intervention and included in the adult clinic population for analysis.
This higher level of VS at baseline meant less opportunity for change over time for participants
in adult clinics. In addition, the adult setting comparison arm had twice the loss to follow-up
as the adult setting intervention arm, while the loss to follow-up was minimal in both study
arms in the pediatric setting. These research findings and biases reinforce the need to further
study AYA experiences in adult HIV clinic settings and to assess if reductions in internalized
stigma lead to increased VS over time. The large increase in VS found among AYA in the pedi-
atric clinic, however, is clear and this is one of the only studies that provides concrete evidence
of program impact on increasing VS in this age group. The fact that the intervention arm par-
ticipants in the pediatric clinic had higher levels of viral failure at baseline (given the transition
of those with viral suppression to adult settings) indicates the potential role Project YES! may
have in the provision of differentiated care focusing on AYA who are experiencing challenges
with their viral status. These findings have direct implications for programing and the need to
incorporate peer mentors into HIV clinic services in pediatric settings.
While the study did not find a significant relative reduction in ART adherence treatment
gaps among intervention versus comparison participants, we did see an overall decrease in
ART adherence treatment gaps from 45.3% to 34.4% in the intervention arm. A limitation of
this study is the adherence measures were self-reported and may reflect social desirability bias.
Newer technologies, like point of care (POC) urine test to measure adherence to Tenofovir-
based regimens [5153], will help to evaluate how programs can improve ART adherence in
future studies.
Other limitations to consider include the individual randomization within clinics that may
have resulted in the comparison arm participants experiencing changes in usual care given
that several clinic staff, during in-depth interviews, reported that participating in Project YES!
changed the way they see and interact with all of their AYA patients [54]. Such changes may
have influenced HIV outcomes among comparison arm participants as they were attended to
by the same HCP as the intervention participants [55]. Purposive sampling of study sites and
consecutive sampling of study participants may also introduce selection bias and limit gener-
alizability of the study findings.
Overall, the Project YES! results establish YPMs as a valuable, underutilized resource to
support AYA living with HIV in an overburdened health care system. Peer mentoring
approaches have worked with other populations [29,30], and contributes to Zambia’s commit-
ment to AYA engagement [44] by training youth to serve not only as peer educators but also
as mentors and role models for their HIV-positive peers. Future research will focus on issues
of scale-up of YPM integration into clinical care using implementation science strategies.
Conclusions
Project YES! provides a feasible and effective clinic-based approach to engage AYA and
improve their HIV-related outcomes. The key intervention component was implemented and
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 15 / 19
led by well-trained and paid youth, exemplifying how a virtually untapped resource in the HIV
epidemic–young people–can successfully engage and shape HIV outcomes among AYA.
Supporting information
S1 Checklist. CONSORT 2010 checklist of information to include when reporting a rando-
mised trial.
(DOC)
S1 Research Plan.
(PDF)
Acknowledgments
The team acknowledges with deep gratitude the adolescent and young adult clients who
engaged in this study. Their resilience remains inspiring. We also thank the heart and soul of
Project YES! the dynamic and amazing youth peer mentors who shared their time and their
experiences with us and made Project YES! a success. We also thank Ms. Teresa Peterson, the
Training and Capacity Building Specialist, for her time and amazing ability to see each per-
son’s potential and to provide the space, tools, and guidance for these young people to become
youth peer mentors. Without the support and guidance of the health care providers and study
team members, this study would not have been possible. We also wish to acknowledge the spe-
cial role of the research advisory board, chaired by Dr. Sam Phiri, that helped keep the study
accountable to the priorities and needs of youth in Zambia.
Author Contributions
Conceptualization: Julie A. Denison.
Data curation: Virginia M. Burke, Christiana Frimpong, Elizabeth A. Abrams.
Formal analysis: Virginia M. Burke, Bareng A. S. Nonyane.
Funding acquisition: Julie A. Denison.
Writing original draft: Julie A. Denison, Bareng A. S. Nonyane.
Writing review & editing: Julie A. Denison, Virginia M. Burke, Sam Miti, Bareng A. S. Non-
yane, Christiana Frimpong, Katherine G. Merrill, Elizabeth A. Abrams, Jonathan K.
Mwansa.
References
1. Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, et al. Antiretroviral therapy
adherence, virologic and immunologic outcomes in adolescents compared with adults in southern
Africa. Journal of acquired immune deficiency syndromes (1999). 2009; 51(1):65–71. Epub 2009/03/14.
https://doi.org/10.1097/QAI.0b013e318199072e PMID: 19282780; PubMed Central PMCID:
PMC2674125.
2. Ding H, Wilson CM, Modjarrad K, McGwin G, Tang J, Vermund SH. Predictors of Suboptimal Virologic
Response to Highly Active Antiretroviral Therapy Among Human Immunodeficiency Virus–Infected
Adolescents: Analyses of the Reaching for Excellence in Adolescent Care and Health (REACH) Project.
Archives of pediatrics & adolescent medicine. 2009; 163(12):1100–5.
3. Ferrand RA, Briggs D, Ferguson J, Penazzato M, Armstrong A, MacPherson P, et al. Viral suppression
in adolescents on antiretroviral treatment: review of the literature and critical appraisal of methodological
challenges. Tropical Medicine & International Health. 2016; 21(3):325–33.
4. Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G, Kershberger B, et al. Factors associated with
virological failure and suppression after enhanced adherence counselling, in children, adolescents and
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 16 / 19
adults on antiretroviral therapy for HIV in Swaziland. PLoS One. 2015; 10(2):e0116144. https://doi.org/
10.1371/journal.pone.0116144 PMID: 25695494
5. World Health Organzation. HIV and adolescents: guidance for HIV testing and counselling and care for
adolescents living with HIV 2013 [cited 2016 February 11, 2016]. Available from: http://apps.who.int/iris/
bitstream/10665/94334/1/9789241506168_eng.pdf?ua=1.
6. Zanoni BC, Archary M, Buchan S, Katz IT, Haberer JE. Systematic review and meta-analysis of the
adolescent HIV continuum of care in South Africa: the Cresting Wave. BMJ global health. 2016; 1(3):
e000004. https://doi.org/10.1136/bmjgh-2015-000004 PMID: 28588949
7. Ministry of Health. Zambia Population-based HIV Impact Assessment (ZAMPHIA) 2016: Final Report.
In: Ministry of Health, editor. Lusaka: Ministry of Health,; 2019.
8. Chakraborty R, Van Dyke RB, Flynn PM, Aldrovandi GM, Chadwick EG, Cooper ER, et al. Transitioning
HIV-Infected Youth Into Adult Health Care. Pediatrics. 2013; 132(1):192–7. https://doi.org/10.1542/
peds.2013-1073 PMID: 23796739
9. Gilliam PP, Ellen JM, Leonard L, Kinsman S, Jevitt CM, Straub DM. Transition of adolescents with HIV
to adult care: characteristics and current practices of the adolescent trials network for HIV/AIDS inter-
ventions. Journal of the Association of Nurses in AIDS Care. 2011; 22(4):283–94. https://doi.org/10.
1016/j.jana.2010.04.003 PMID: 20541443
10. Pequegnat W, Bauman LJ, Bray JH, DiClemente R, DiIorio C, Hoppe SK, et al. Measurement of the
role of families in prevention and adaptation to HIV/AIDS. AIDS and Behavior. 2001; 5(1):1–19.
11. Pequegnat W, Bell C. Family and HIV/AIDS: Cultural and contextual issues in prevention and treatment:
Springer Science & Business Media; 2011.
12. Pequegnat W, Szapocznik J. Working with families in the era of HIV/AIDS: Sage; 2000.
13. Thurman TR, Jarabi B, Rice J. Caring for the caregiver: evaluation of support groups for guardians of
orphans and vulnerable children in Kenya. AIDS care. 2012; 24(7):811–9. https://doi.org/10.1080/
09540121.2011.644229 PMID: 22299721
14. Perrino T, Gonza
´lez-Soldevilla A, Pantin H, Szapocznik J. The role of families in adolescent HIV pre-
vention: A review. Clinical child and family psychology review. 2000; 3(2):81–96. https://doi.org/10.
1023/a:1009571518900 PMID: 11227063
15. Sanders RA. Adolescent psychosocial, social, and cognitive development. Pediatrics in review/Ameri-
can Academy of Pediatrics. 2013; 34(8):354–8.
16. Duffy M, H B, Sharer M. Toolkit for Transition of care and other services for adolescents living with HIV
Arlington, VA: USAID’s AIDS Support and Technical Assistance Resources, AIDSTAR-One, Task
Order 1; 2014 [cited 2016 February 11, 2016]. Available from: https://aidsfree.usaid.gov/sites/default/
files/final_alhivtoolkit_web.pdf.
17. Reiss J, Gibson R. Health care transition: destinations unknown. Pediatrics. 2002; 110(Supplement
3):1307–14.
18. Amzel A, Toska E, Lovich R, Widyono M, Patel T, Foti C, et al. Promoting a combination approach to
paediatric HIV psychosocial support. AIDS. 2013; 27:S147–S57. https://doi.org/10.1097/QAD.
0000000000000098 PMID: 24361624
19. Sawyer SM, Drew S, Yeo MS, Britto MT. Adolescents with a chronic condition: challenges living, chal-
lenges treating. The Lancet. 2007; 369(9571):1481–9.
20. Rosen DS, Blum RW, Britto M, Sawyer SM, Siegel DM. Transition to adult health care for adolescents
and young adults with chronic conditions: position paper of the Society for Adolescent Medicine. Journal
of Adolescent Health. 2003; 33(4):309–11. https://doi.org/10.1016/s1054-139x(03)00208-8 PMID:
14519573
21. Ridgeway K, Dulli LS, Murray KR, Silverstein H, Dal Santo L, Olsen P, et al. Interventions to improve
antiretroviral therapy adherence among adolescents in low-and middle-income countries: A systematic
review of the literature. PloS one. 2018; 13(1):e0189770. https://doi.org/10.1371/journal.pone.0189770
PMID: 29293523
22. Hussen SA, Chahroudi A, Boylan A, Camacho-Gonzalez AF, Hackett S, Chakraborty R. Transition of
youth living with HIV from pediatric to adult-oriented healthcare: a review of the literature. Future virol-
ogy. 2015; 9(10):921–9. https://doi.org/10.2217/fvl.14.73 PMID: 25983853
23. Bal MI, Sattoe JN, Roelofs PD, Bal R, van Staa A, Miedema HS. Exploring effectiveness and effective
components of self-management interventions for young people with chronic physical conditions: A sys-
tematic review. Patient education and counseling. 2016.
24. Lerner RM, Lerner JV, Almerigi J, Theokas C, Phelps E, Naudeau S, et al. Towards a new vision and
vocabulary about adolescence: Theoretical, empirical, and applied bases of a “Positive Youth Develop-
ment” perspective. In: Balter L, & Tamis-LeMonda C. S., editor. Child psychology: A handbook of con-
temporary issues. New York: Psychology Press/Taylor & Francis; 2006. p. 445–69.
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 17 / 19
25. Lerner RM A-ZM, Bebiroglu N, Brittian A, Lynch A. Positive Youth Development In: DiClemente R SJ,
Crosby R.: Bass Jossey, editor. Adolescent Health: Understanding and Preventing Risk Behaviors.
San Fransisco, CA: John Wiley & Sons; 2009.
26. Catalano RE, Skinner ML, Alvarado G, Kapungu C, Reavley N, Patton GC JC, et al. Positive Youth
Development Programs in Low- and Middle-Income Countries: A Conceptual Framework and System-
atic Review of Efficacy. J Adolesc Health. 2019; 65(1):15–31. Epub 2019 Apr 19. https://doi.org/10.
1016/j.jadohealth.2019.01.024 PMID: 31010725
27. Bandura A. Social cognitive theory: An agentic perspective. Annual review of psychology. 2001; 52
(1):1–26.
28. Bandura A. Social cognitive theory of self-regulation. Organizational behavior and human decision pro-
cesses. 1991; 50(2):248–87.
29. Futterman D, Shea J, Besser M, Stafford S, Desmond K, Comulada WS, et al. Mamekhaya: a pilot
study combining a cognitive-behavioral intervention and mentor mothers with PMTCT services in South
Africa. AIDS care. 2010; 22(9):1093–100. https://doi.org/10.1080/09540121003600352 PMID:
20824562
30. Denison JA, Tsui S, Bratt J, Torpey K, Weaver MA, Kabaso M. Do peer educators make a difference?
An evaluation of a youth-led HIV prevention model in Zambian Schools. Health education research.
2012; 27(2):237–47. https://doi.org/10.1093/her/cyr093 PMID: 21987477
31. FHI360. Adolescents Living with HIV in Zambia: An Examination of HIV Care and Treatment and Family
Planning: FHI 360; 2013 [cited 2019 June 23]. Available from: https://www.fhi360.org/sites/default/files/
media/documents/zambia-adolescents-living-hiv-integration-family-planning.pdf.
32. Mburu G, Ram M, Skovdal M, Bitira D, Hodgson I, Mwai GW, et al. Resisting and challenging stigma in
Uganda: the role of support groups of people living with HIV. Journal of the International AIDS Society.
2013; 16(3S2).
33. World Health Organzation. HIV and adolescents: Guidance for HIV testing and counselling and care for
adolescents living with HIV: Recommendations for a public health approach and considerations for pol-
icy-makers and managers 2013. June 5,.
34. World Health Organization. A qualitative review of psychosocial support interventions for young people
living with HIV. Geneva: World Health Organization, 2009.
35. Lee S, Hazra R. Achieving 90-90-90 in paediatric HIV: adolescence as the touchstone for transition suc-
cess. Journal of the International AIDS Society. 2015; 18(7).
36. UNAIDS. Fast-track: ending the AIDS epidemic by 2030 2014 [cited 2019 June 29]. Available from:
https://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf.
37. Ryan P. RALLOC: Stata module to design randomized controlled trials. 2011.
38. StataCorp. Stata Statistical Software: Release 14. StataCorp LP; 2015.
39. FHI360. Positive Connections: Leading Information and Support Groups for Adolescents Living with
HIV. Durham, NC: FHI360; 2013 [cited 2019 July 23]. Available from: https://www.fhi360.org/sites/
default/files/media/documents/positive-connections-2013.pdf.
40. Denison JA, Banda H, Dennis AC, Packer C, Nyambe N, Stalter RM,et al. ‘‘The sky is the limit”: adher-
ing to antiretroviral therapy and HIV self-management from the perspectives of adolescents living with
HIV and their adult caregivers. Journal of the International AIDS Society. 2015; 18(1).
41. Denison JA, Packer C, Stalter RM, Banda H, Mercer S, Nyambe N, et al. Factors related to incomplete
adherence to antiretroviral therapy among adolescents attending three HIV clinics in the copperbelt,
Zambia. AIDS and behavior. 2018; 22(3):996–1005. https://doi.org/10.1007/s10461-017-1944-x PMID:
29103190
42. Kalichman SC, Simbayi LC, Cloete A, Mthembu PP, Mkhonta RN, Ginindza T. Measuring AIDS stigmas
in people living with HIV/AIDS: the Internalized AIDS-Related Stigma Scale. AIDS Care. 2009; 21
(1):87–93. Epub 2008/12/17. https://doi.org/10.1080/09540120802032627 PMID: 19085224.
43. Zambia. The Health Services Research Act 2013 2013 [cited 2019 July 3]. Available from: http://www.
parliament.gov.zm/sites/default/files/documents/acts/Health%20%20Research%20%20Act%202013.
pdf.
44. Zambia Ministry of Health. A Comprehensive Manual for Adolescent Peer Educators Facilitator’s
Guide. Lusaka, Zambia: Zambia MOH,; 2016.
45. World Health Organzation. Health for the World’s Adolescents: A second chance in the second decade
2014 [cited 2019 June 23,]. Available from: http://apps.who.int/adolescent/second-decade/section2/
page5/adolescence-psychological-and-social-changes.html.
46. Pantelic M, Steinert JI, Park J, Mellors S, Murau F. ‘Management of a spoiled identity’: systematic
review of interventions to address self-stigma among people living with and affected by HIV. BMJ global
health. 2019; 4(2):e001285. https://doi.org/10.1136/bmjgh-2018-001285 PMID: 30997170
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 18 / 19
47. Rongkavilit C, Wang B, Naar-King S, Bunupuradah T, Parsons JT, Panthong A, et al. Motivational inter-
viewing targeting risky sex in HIV-positive young Thai men who have sex with men. Archives of sexual
behavior. 2015; 44(2):329–40. https://doi.org/10.1007/s10508-014-0274-6 PMID: 24668304
48. Kirk S, Hinton D. “I’m not what I used to be”: A qualitative study exploring how young people experience
being diagnosed with a chronic illness. Child: care, health and development. 2019; 45(2):216–26.
49. Monaghan LF, Gabe J. Managing Stigma: Young People, Asthma, and the Politics of Chronic Illness.
Qualitative health research. 2018:1049732318808521.
50. Wicks S, Berger Z, Camic PM. It’s how I am . . . it’s what I am . . . it’s a part of who I am: A narrative explo-
ration of the impact of adolescent-onset chronic illness on identity formation in young people. Clinical
child psychology and psychiatry. 2019; 24(1):40–52. https://doi.org/10.1177/1359104518818868
PMID: 30789046
51. Daughtridge G, Hebel S, Fischl M, Hashim J, Kahn-Woords E, K. K, editors. Development and valida-
tion of a point-of-care, urine assay to measure adherence to PrEP and ART Mexico City: International
AIDS Society;. International AIDS Society (IAS) Conference on HIV Science; 2019; Mexico City,
Mexico.
52. Hunt T, Lalley-Chareczko L, Daughtridge G, Swyryn M, Koenig H. Challenges to PrEP use and percep-
tions of urine tenofovir adherence monitoring reported by individuals on PrEP. AIDS care. 2019:1–4.
53. Spinelli MA, Glidden DV, Rodrigues WC, Wang G, Vincent M, Okochi H, et al. Low tenofovir level in
urine by a novel immunoassay is associated with seroconversion in a preexposure prophylaxis demon-
stration project. Aids. 2019; 33(5):867–72. https://doi.org/10.1097/QAD.0000000000002135 PMID:
30649051
54. Abrams E, Burke V, Merrill K, Frimpong C, Miti S, Mwansa J, et al. Health care provider perspectives of
a youth HIV peer mentoring program in Ndola, Zambia. to be submiitted. 2019.
55. Wilson KS, Mugo C, Moraa H, Onyango A, Nduati M, Inwani I, et al. Health provider training is associ-
ated with improved engagement in HIV care among adolescents and young adults in Kenya. AIDS.
2019; 33(9):1501–10. https://doi.org/10.1097/QAD.0000000000002217 PMID: 30932957
PLOS ONE
Peer mentoring impact on viral suppression, adherence and stigma among HIV-positive Zambian youth
PLOS ONE | https://doi.org/10.1371/journal.pone.0230703 April 2, 2020 19 / 19
... The CDC currently lists 29 Medication Adherence Evidence-based Behavioral Interventions [6]. Three of these are youth specific including Project Yes! [7], Text Messaging [8], and Project nGage [9]. Project Yes! was an HIV clinic-based peer mentoring program for youth ages [15][16][17][18][19][20][21][22][23][24] in sub-Saharan Africa, and 72% of the participants acquired HIV through perinatal transmission. ...
... Project Yes! was an HIV clinic-based peer mentoring program for youth ages [15][16][17][18][19][20][21][22][23][24] in sub-Saharan Africa, and 72% of the participants acquired HIV through perinatal transmission. There were significant improvements in viral load suppression at 6 months in the intervention group [7]. The Text Messaging intervention studied two-way text messaging in youth ages [16][17][18][19][20][21][22][23][24][25][26][27][28][29] from Chicago, which demonstrated significant improvements with greater than 90% self-reported adherence at both 3 and 6 months. ...
Article
Full-text available
Youth living with HIV have low rates of medication adherence. Youth ages 15–24 years with adherence ≤ 80% or with HIV RNA PCRs (VL) ≥ 200 recruited through social media and clinical sites were randomized to brief weekday cell phone support (CPS) calls or daily, two-way, personalized text message (SMS) reminders for 3 months. Those with VL ≥ 200 or adherence ≤ 80% were rerandomized to receive SMS or CPS with monthly incentives for those utilizing the intervention at least 75% of days for 3 months. Those with VL < 200 or adherence > 80% after the initial 3 months were rerandomized to usual care or 3 months of tapered, 2x/week CPS or SMS. Self-reported adherence and VLs were collected every 3 months for one year. Eighty-three youth were recruited with 81% identifying as cisgender males, 55% Black, 22% Latine/x, and 76% gay, and 56% recruited from the Southern US. Both cohorts initially randomized to CPS and SMS demonstrated significant improvements in adherence over the 12-months (P <.001). Participants randomized to CPS had significant improvements in 7-day self-reported adherence over 12 months compared to those on SMS (P <.027). Those receiving a tapered intervention for an additional 3 months had improved self-reported adherence compared to those randomized to the standard of care arm (P <.001). Both SMS and CPS appear to be effective interventions for youth with poor antiretroviral adherence. Tapering the intervention for an additional 3 months is useful in maintaining adherence after the initial intervention. Additional research is required to determine how to best sequence these interventions, including the use of incentives. Graphical Abstract
... Among the three studies, EnPrEP was conducted in person to improve PrEP initiation and use while Passport to Wellness and PrEP Peer Leaders were done remotely to increase adherence. However, the CDC's PRS project has identified 31 peer-based Best Practices to improve various HIV-related outcomes such as increasing consistent condom use [47,48], increasing HIV testing [49], and improving HIV care outcomes [50][51][52][53][54][55]. HIV peer navigation services is one of the public health practices for the EHE's Treat Pillar (https:// www. ...
Article
Full-text available
A qualitative systematic review was conducted to evaluate pre-exposure prophylaxis (PrEP) interventions, describe characteristics of best practices for increasing PrEP use and persistence, and explore research gaps based on current PrEP interventions. We searched CDC’s Prevention Research Synthesis (PRS) Project’s cumulative HIV database (includes CINAHL, EMBASE, Global Health, MEDLINE, PsycInfo, and Sociological Abstracts) to identify PrEP intervention studies conducted in the U.S., published between 2000 and 2022 (last searched January 2023). Eligibility criteria include studies that evaluated PrEP interventions for persons testing negative for HIV infection, or for healthcare providers who prescribed PrEP; included comparisons between groups or pre/post; and reported at least one relevant PrEP outcome. Each eligible intervention was evaluated on the quality of study design, implementation, analysis, and strength of evidence (PROSPERO registration number: CRD42021256460). Of the 26 eligible interventions, the majority were focused on men who have sex with men (n = 18) and reported PrEP adherence outcomes (n = 12). Nine interventions met the criteria for Best Practices (i.e., evidence-based interventions, evidence-informed interventions). Five were digital health interventions while two implemented individual counseling, one offered motivational interviewing, and one provided integrated medical care with a PrEP peer navigator. Longer intervention periods may provide more time for intervention exposure to facilitate behavioral change, and engaging the community when developing, designing and implementing interventions may be key for effectiveness. For digital health interventions, two-way messaging may help participants feel supported. Research gaps included a lack of Best Practices for several populations (e.g., Black persons, Hispanic/Latino persons, persons who inject drugs, and women of color) and evidence for various intervention strategies (e.g., interventions for promoting provider’s PrEP prescription behavior, peer support). These findings call for more collaborative work with communities to develop interventions that work and implement and disseminate Best Practices for increasing PrEP use and persistence in communities.
... Developing specifically tailored interventions for reducing internalized HIV stigma for heterosexual individuals may be an effective approach in getting heterosexual PLWH to initiate and stay engaged in HIV care. This type of approach has worked well to reduce HIV stigma among other subgroups, such as Black women (Rao et al., 2012) and youth (Denison et al., 2020), acknowledging the potential reach of an intervention specifically designed to combat internalized HIV stigma among heterosexual individuals. ...
Article
Full-text available
Internalized HIV stigma has been associated with several poor mental and physical health outcomes among people living with HIV (PLWH); yet, little research has explored how internalized HIV stigma may be affected by syndemic burden. This study sought to examine the relationship between syndemic conditions and HIV stigma over and above the potential effects of two social determinants of health, age and sexual minority status, using a linear regression approach ( N = 1343). Syndemic burden was significantly positively associated with internalized HIV stigma above and beyond the effects of age and sexual minority status ( b = 0.23). Additionally, age ( b = −0.02) and being a sexually minority ( b = −0.31) were significantly negatively associated with internalized HIV stigma. Findings should inform future treatment targets for this population by specifically working to reduce internalized HIV stigma for people with a greater syndemic burden and, potentially, among young adults and heterosexual PLWH.
... This is more likely linked to fear that close family members will reject them once they reveal their HIV positive status. Similar findings also highlight the association between HIV care and internalised stigma [38][39][40][41]. Internalised stigma has been found in other studies to be associated with depression and other mental health issues [42][43][44]. ...
Article
Full-text available
South Africa has the largest share of people living with HIV in the world and this population is ageing. The social context in which people seek HIV care is often ignored. Apart from clinical interventions, socio-behavioural factors impact successful HIV care outcomes for older adults living with HIV. We use cross-sectional data linked with demographic household surveillance data, consisting of HIV positive adults aged above 40, to identify socio-behavioural predictors of a detectable viral load. Older adults were more likely to have a detectable viral load if they did not disclose their HIV positive status to close family members (aOR 2.56, 95% CI 1.89-3.46), resided in the poorest households (aOR 1.98, 95% CI 1.23-3.18), or were not taking medications other than ART (aOR 1.83, 95% CI 1.02-1.99) likely to have a detectable. Clinical interventions in HIV care must be supported by understanding the socio-behavioural barriers that occur outside the health facility. The importance of community health care workers in bridging this gap may offer more optimum outcomes for older adults ageing with HIV.
Article
Objective This meta-analysis examined the efficacy of adherence-promotion interventions for children, adolescents, and young adults prescribed a medication for > 90 days as part of a treatment regimen for a medical condition. Methods A systematic literature review was conducted to identify randomized controlled trials of adherence-promotion interventions published between 2013 and 2023 and including children, adolescents, and/or young adults with a medical condition. A total of 38 articles representing 39 trials met inclusion criteria. A narrative synthesis was conducted to summarize included trials and a random-effects model was used to compute an overall intervention effect. Effect sizes by adherence outcome assessment methodology, participant age, and technology use were also computed. Results Pediatric adherence-promotion interventions demonstrate a medium effect with those randomized to an intervention displaying greater improvements in medication adherence than those randomized to a comparator condition (SMD = 0.46, 95% CI: 0.31, 0.60, n = 37; 95% Prediction Interval: −0.32, 1.23). Conclusions Adherence interventions for children, adolescents, and young adults with medical conditions increase adherence.
Chapter
Chronic illnesses affect one in four children in the United States, equating to fifteen to eighteen million children, according to epidemiologic studies. Navigating medication adherence is among the numerous challenges that these illnesses pose to children and their families. The ability to successfully adhere to these treatments can be defined as “self-management” and is influenced by factors within four domains: individual, family, community, and health-based systems. In minoritized populations, additional considerations, including perception of illness, perceived discrimination, and language barriers are relevant to self-management behaviors. In this chapter we present the strategies that address factors within pertinent domains affecting nonadherence, particularly those prevalent in minoritized youth and their families. In doing so, we stress solutions that accommodate children of different age groups, incorporate parental and guardian perspectives, and foster alliances between healthcare providers and families.
Article
Persons with HIV-associated Kaposi’s sarcoma (KS) experience three co-existing stigmatizing health conditions: skin disease, HIV, and cancer, which contribute to a complex experience of stigmatization and to delays in diagnosis and treatment. Despite the importance of stigma among these patients, there are few proven stigma-reduction strategies for HIV-associated malignancies. Using qualitative methods, we explore how people with HIV-associated KS in western Kenya between August 2022 and 2023 describe changes in their stigma experience after participation in a multicomponent navigation strategy, which included 1) physical navigation and care coordination, 2) video-based education with motivational survivor stories, 3) travel stipend, 4) health insurance enrollment assistance, 5) health insurance stipend, and 6) peer mentorship. A purposive sample of persons at different stages of chemotherapy treatment were invited to participate. Participants described how a multicomponent navigation strategy contributed to increased knowledge and awareness, a sense of belonging, hope to survive, encouragement, and social support, which served as stigma mitigators, likely counteracting the major drivers of intersectional stigma in HIV-associated KS.
Article
Full-text available
Background Self-stigma, also known as internalised stigma, is a global public health threat because it keeps people from accessing HIV and other health services. By hampering HIV testing, treatment and prevention, self-stigma can compromise the sustainability of health interventions and have serious epidemiological consequences. This review synthesised existing evidence of interventions aiming to reduce self-stigma experienced by people living with HIV and key populations affected by HIV in low-income and middle-income countries. Methods Studies were identified through bibliographic databases, grey literature sites, study registries, back referencing and contacts with researchers, and synthesised following Cochrane guidelines. Results Of 5880 potentially relevant titles, 20 studies were included in the review. Represented in these studies were 9536 people (65% women) from Ethiopia, India, Kenya, Lesotho, Malawi, Nepal, South Africa, Swaziland, Tanzania, Thailand, Uganda and Vietnam. Seventeen of the studies recruited people living with HIV (of which five focused specifically on pregnant women). The remaining three studies focused on young men who have sex with men, female sex workers and men who inject drugs. Studies were clustered into four categories based on the socioecological level of risk or resilience that they targeted: (1) individual level only, (2) individual and relational levels, (3) individual and structural levels and (4) structural level only. Thirteen studies targeting structural risks (with or without individual components) consistently produced significant reductions in self-stigma. The remaining seven studies that did not include a component to address structural risks produced mixed effects. Conclusion Structural interventions such as scale-up of antiretroviral treatment, prevention of medication stockouts, social empowerment and economic strengthening may help substantially reduce self-stigma among individuals. More research is urgently needed to understand how to reduce self-stigma among young people and key populations, as well as how to tackle intersectional self-stigma.
Article
Full-text available
Introduction Globally, an estimated 30% of new HIV infections occur among adolescents (15–24 years), most of whom reside in sub-Saharan Africa. Moreover, HIV-related mortality increased by 50% between 2005 and 2012 for adolescents 10–19 years while it decreased by 30% for all other age groups. Efforts to achieve and maintain optimal adherence to antiretroviral therapy are essential to ensuring viral suppression, good long-term health outcomes, and survival for young people. Evidence-based strategies to improve adherence among adolescents living with HIV are therefore a critical part of the response to the epidemic. Methods We conducted a systematic review of the peer-reviewed and grey literature published between 2010 and 2015 to identify interventions designed to improve antiretroviral adherence among adults and adolescents in low- and middle-income countries. We systematically searched PubMed, Web of Science, Popline, the AIDSFree Resource Library, and the USAID Development Experience Clearinghouse to identify relevant publications and used the NIH NHLBI Quality Assessment Tools to assess the quality and risk of bias of each study. Results and discussion We identified 52 peer-reviewed journal articles describing 51 distinct interventions out of a total of 13,429 potentially relevant publications. Forty-three interventions were conducted among adults, six included adults and adolescents, and two were conducted among adolescents only. All studies were conducted in low- and middle-income countries, most of these (n = 32) in sub-Saharan Africa. Individual or group adherence counseling (n = 12), mobile health (mHealth) interventions (n = 13), and community- and home-based care (n = 12) were the most common types of interventions reported. Methodological challenges plagued many studies, limiting the strength of the available evidence. However, task shifting, community-based adherence support, mHealth platforms, and group adherence counseling emerged as strategies used in adult populations that show promise for adaptation and testing among adolescents. Conclusions Despite the sizeable body of evidence for adults, few studies were high quality and no single intervention strategy stood out as definitively warranting adaptation for adolescents. Among adolescents, current evidence is both sparse and lacking in its quality. These findings highlight a pressing need to develop and test targeted intervention strategies to improve adherence among this high-priority population.
Article
Purpose: Positive youth development (PYD) has served as a framework for youth programs in high-income countries since the 1990s and has demonstrated broad behavioral health and developmental benefits. PYD programs build skills, assets, and competencies; foster youth agency; build healthy relationships; strengthen the environment; and transform systems to prepare youth for successful adulthood. The goal of this article was to systematically review the impact of PYD programs in low- and middle-income countries (LMICs). Methods: Targeted searches of knowledge repository Web sites and keyword searches of Scopus and PubMed identified over 21,500 articles and over 3,700 evaluation reports published between 1990 and mid-2016. Ninety-four PYD programs with evaluations in LMICs were identified, of which 35 had at least one experimental or rigorous quasi-experimental evaluation. Results: Sixty percent of the 35 programs with rigorous evaluations demonstrated positive effects on behaviors, including substance use and risky sexual activity, and/or more distal developmental outcomes, such as employment and health indicators. Conclusions: There is promising evidence that PYD programs can be effective in LMICs; however, more rigorous examination with long-term follow-up is required to establish if these programs offer benefits similar to those seen in higher income countries.
Article
Objectives: Adolescents and young adults (AYA) have poorer retention, viral suppression, and survival than other age groups. We evaluated correlates of initial AYA engagement in HIV care at facilities participating in a randomized trial in Kenya. Design: Retrospective cohort study. Methods: Electronic medical records from AYA ages 10-24 attending 24 HIV care facilities in Kenya were abstracted. Facility surveys assessed provider trainings and services. HIV provider surveys assessed AYA training and work experience. Engagement in care was defined as return for first follow-up visit within 3 months among newly enrolled or recently re-engaged (returning after >3 months out of care) AYA. Multilevel regression estimated risk ratios and 95% confidence intervals (CIs), accounting for clustering by facility. Final models adjusted for AYA individual age and median AYA age and number enrolled per facility. Results: Among 3662 AYA records at first eligible visit, most were female (75.1%), older (20-24 years: 54.5%), and on antiretroviral therapy (79.5%). Overall, 2639 AYA returned for care (72.1%) after enrollment or re-engagement visit. Engagement in care among AYA was significantly higher at facilities offering provider training in adolescent-friendly care (85.5 vs. 67.7%; adjusted risk ratio (aRR) 1.11, 95% CI: 1.01-1.22) and that used the Kenyan government's AYA care checklist (88.9 vs. 69.2%; aRR 1.14, 95% CI: 1.06-1.23). Engagement was also significantly higher at facilities where providers reported being trained in AYA HIV care (aRR 1.56, 95% CI: 1.13-2.16). Conclusion: Adolescent-specific health provider training and tools may improve quality of care and subsequent AYA engagement. Health provider interventions are needed to achieve the '95-95-95' targets for AYA.
Article
Maximizing the impact of HIV pre-exposure prophylaxis (PrEP) requires optimizing access and adherence for those at risk of contracting HIV. This study examined challenges to the processes of accessing and adhering to PrEP encountered by participants from a large, U.S. urban clinical center and assessed the utility of objectively monitoring PrEP adherence via urine. Most participants (65%) reported starting PrEP within 1–3 months of hearing about it, although 35% of participants encountered a provider unwilling to prescribe PrEP. Self-reported adherence was high among this population, with remembering to take the medication reported as the major barrier to adherence (44%) rather than cost or stigma. Urine tenofovir (TFV) monitoring was highly acceptable to this population, and participants indicated greater willingness to undergo urine monitoring every 3 months compared to finger prick (dried blood spot), phlebotomy, or hair follicle testing. These findings highlight the importance of focusing efforts toward reducing obstacles to PrEP use and support the use of urine TFV adherence monitoring as a marker of PrEP adherence.
Article
Background Childhood long‐term conditions are usually diagnosed in infancy or early childhood. Little is known about the particular experiences and needs of young people who receive a chronic illness diagnosis during adolescence or late childhood. This paper will examine this experience in relation to Multiple Sclerosis (MS) which is increasingly being diagnosed before adulthood. Aims To explore how young people experience an MS diagnosis. Methods Qualitative study using a grounded theory approach. In‐depth interviews were conducted with 21 young people diagnosed with MS. Participants were recruited through health service and voluntary sector organisations in the United Kingdom. Findings Young people's pre‐illness normality was disrupted by the diagnosis of a chronic illness (MS). Participants experienced their body as changed physically, cognitively and emotionally and as changeable due to symptom unpredictability. This influenced how participants perceived and presented their identity, disrupted their relationships and altered their future biography. Young people developed strategies to manage their condition and identities in order to incorporate MS into their current and future lives which required continual illness and identity work in response to changing symptoms, social contexts and relationships. Conclusions While young peoples’ experience of living with chronic illness has been widely explored, the aftermath of diagnosis has been under‐researched from their perspective. This study contributes to this knowledge gap by illuminating how young people experience a chronic illness diagnosis and negotiate the resulting changes to their identity, relationships and future. The findings suggest that young people need preparation and support in disclosing their diagnosis to others. Professionals supporting young people with long‐term conditions need to work closely with specialist mental health services to ensure they receive appropriate emotional support. Schools have an important role in ensuring young people with long‐term conditions achieve their academic potential and receive appropriate careers advice.
Article
Objective: We examined the relationship between urine tenofovir (TFV) levels measured with a novel immunoassay, which permits point-of-care testing, with HIV seroconversion and objective adherence metrics in a large preexposure prophylaxis (PrEP) demonstration project. Design: Secondary analysis of stored specimens from an open-label PrEP cohort study. Methods: We examined the association between undetectable urine TFV levels and HIV seroconversion in iPrEx open-label extension using generalized estimating equations. We examined rank correlations between levels of TFV and emtricitabine in urine, dried blood spots (DBS), and hair and determined the sensitivity and specificity of undetectable urine TFV for predicting dosing cut-offs in DBS. Results: The median urinary TFV level was 15 000 ng/ml in those who remained HIV-negative (n = 105; interquartile range: 1000-45 000); 5500 in those who eventually seroconverted (n = 11; interquartile range: 1000-12 500); and all were undetectable at seroconversion (n = 9; P < 0.001). Decreasing strata of urine TFV levels were associated with future HIV seroconversion (P = 0.03). An undetectable urine TFV was 100% sensitive and 81% specific when compared with an undetectable DBS TFV-diphosphate level and 69% sensitive, but 94% specific when compared with low adherence by DBS (<2 doses/week). Conclusion: Urine TFV detection by a novel antibody-based assay was associated with protection from HIV acquisition among individuals on PrEP. Urine TFV levels were correlated with hair and DBS levels and undetectable urine TFV was 100% sensitive in detecting nonadherence. By implementing the immunoassay into a point-of-care strip test, PrEP nonadherence could be detected in real-time, allowing rapid intervention.
Article
In Western society, identity formation is argued to be one of the key developmental tasks of adolescence. Despite implications for adolescent development, research into chronic illness (CI) onset during this period has been notably sparse. This study aimed to explore how diagnosis impacts on the developmental tasks of adolescence, what role adolescent-onset CI plays in identity formation, and how adolescents incorporate the diagnosis into their identity using a narrative analysis. Individual semi-structured interviews were carried out with eight young people aged 14 to 19years who lived with a diagnosis of a CI diagnosed between the ages of 12 and 16 years. Five core narrative themes emerged: walking a different path, tolerating contradiction, a changed interface with others, locating power and a fluid relationship. Narratives were considered to have been influenced by factors such as the interview context and dominant social narratives concerning health and illness. Adolescent-onset CI was found to have a significant, though not exclusively negative, impact on developmental tasks. The findings are discussed in relation to existing literature and potential clinical implications.
Article
In this article, we explore the relationship between asthma and stigma, drawing on 31 interviews with young people (aged 5-17) in Ireland. Participants with mild to moderate asthma were recruited from Traveller and middle-class settled communities. Themes derived from an abductive approach to data analysis and a critical appreciation of Goffmanesque sociology include asthma as a discreditable stigma, negative social reactions (real, imagined, and anticipated), and stigma management. Going beyond a personal tragedy model, we reflect upon macro-social structures (e.g., ethnicity, class, gender) which underlie stigma and the management of a potentially spoiled identity. This raises issues about the politics of chronic illness, embodying health identities and efforts to tackle stigma in neoliberal times.